Inhibikase Therapeutics, Inc. (IKT) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$518
Total Return
-94.82%
CAGR
-44.68%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.02% |
| Median | -5.22% |
| Best | +176.72% |
| Worst | -61.54% |
| % of Windows Positive | 39.1% |
1-Year (252 Trading Days)
| Average | -21.79% |
| Median | -41.96% |
| Best | +226.20% |
| Worst | -85.06% |
| % of Windows Positive | 22.5% |
3-Year (756 Trading Days)
| Average | -68.46% |
| Median | -68.27% |
| Best | -27.18% |
| Worst | -95.73% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -97.81% |
| Average Drawdown | -88.40% |
| Drawdown Duration | 1249 Trading Days (Unrecovered) |
| Sortino Ratio | -0.19 |
| Calmar Ratio | -0.46 |
| CVaR (5%) | -12.81% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -18.54% (-38.51% ann.) | $1853.85 | $0.00 | $0.00 | $0.00 |
| 2025 | -36.92% | $3692.29 | $0.00 | $0.00 | $0.00 |
| 2024 | +155.91% | +$15591.21 | $0.00 | $0.00 | $0.00 |
| 2023 | -57.67% | $5766.76 | $0.00 | $0.00 | $0.00 |
| 2022 | -65.99% | $6598.65 | $0.00 | $0.00 | $0.00 |
| 2021 | -78.70% | $7869.56 | $0.00 | $0.00 | $0.00 |
| 2020 partial | -30.30% (-100.00% ann.) | $3030.30 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Reopening reflation / fiscal boom / supply bottlenecks partial | December 23, 2020 – November 29, 2021 | -78.48% | -80.71% | $7848.48 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -77.00% | -79.00% | $7699.98 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -59.72% | -38.77% | $5972.16 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +42.73% | +23.19% | +$4273.24 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.